A1. Novel Agents
Poster Session: Novel Agents
Sailaja Puttagunta, MD
Chief Medical Officer
Iterum Therapeutics
Old Saybrook, Connecticut, United States
Steven I. Aronin, MD
Senior Vice President and Head of Clinical Development
Iterum Therapeutics
Old Saybrook, CT, United States
Stephanie Halasohoris, PhD
U.S. Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
Ashley Babyak, PhD
U.S. Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
Jade Spencer, PhD
U.S. Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
Annette Gray, PhD
U.S. Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
Marjorie Torres, PhD
U.S. Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
Christopher Klimko, PhD
U.S. Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
Christopher Cote, PhD
U.S. Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
Mary Hourihan, PhD
U.S. Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
James Meinig, PhD
U.S. Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States